Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hanmi Semiconductor (042700) – Submission of Audit Report / 2026-03-12

Posted on March 12, 2026July 31, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanmi Semiconductor (042700) – Submission of Audit Report / 2026-03-12

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Hanmi Semiconductor submitted its audit report for the 2025 fiscal year, receiving an ‘Unqualified’ audit opinion from KPMG Samjong for both consolidated and separate financial statements.

📊 [Key Disclosure Contents & Summary of Major Figures]

  1. Audit Information & Opinions
  • External Auditor: KPMG Samjong
  • Date of Audit Report Receipt: 2026-03-12
  • Consolidated Audit Opinion: Unqualified (No material uncertainty related to going concern)
  • Separate Audit Opinion: Unqualified (No material uncertainty related to going concern)
  • Internal Accounting Control System Opinion: Qualified/Unqualified Issues: None (Not Applicable)
  • Details of Embezzlement/Breach of Trust in Audit Report: No
  1. Consolidated Financials & Income Highlights (Current Fiscal Year)
  • Total Assets: KRW 813.3B
  • Total Liabilities: KRW 123.0B
  • Total Equity: KRW 690.3B
  • Capital Stock: KRW 12.7B
  • Revenue: KRW 576.7B
  • Operating Profit: KRW 251.4B
  • Profit Before Income Tax: KRW 278.4B
  • Net Income: KRW 214.0B
  • Number of Consolidated Subsidiaries: 3
  1. Separate Financials & Income Highlights (Current Fiscal Year)
  • Total Assets: KRW 798.6B
  • Total Liabilities: KRW 124.8B
  • Total Equity: KRW 673.8B
  • Revenue: KRW 559.7B
  • Operating Profit: KRW 242.4B
  • Net Income: KRW 208.3B
  1. Other Notes
  • The financial statements in this audit report are subject to potential changes during the approval process at the Annual General Meeting of Shareholders.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Shareholder Approval and Finalized Financial Statements

While the financial figures in this audit report reflect the completed external audit, finalization occurs upon approval at the Annual General Meeting of Shareholders. Checking whether the financial statements are approved without modifications at the general meeting is important to confirm the finalized financial figures. Related details can be verified through future disclosures on general meeting results or annual periodic reports.

📢 Disclaimer & Source Notice

Source: This content was structured and newly generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in the US / 2026-03-12
Next Post: [Disclosure] Hanwha Systems (272210) – Change in Completion Date for KRW 125.0B Supply Contract with Naval Logistics Command (Extended to August 31, 2026)

Related Posts

[Disclosure] Celltrion (068270) – Approval of U.S. FDA BLA for Stoboclo & Osenvelt (CT-P41, Prolia & Xgeva Biosimilars) / 2025-03-04 Disclosures
[Disclosure] SK square (402340) – Change in Revenues or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2026-02-10 Semiconductors
[Disclosure] Hyundai Motor Company (005380) – Notice of Investor Relations (IR) Event for Q4 2025 Earnings Release Disclosures
[Disclosure] SK square (402340) – Removal of Subsidiary from Holding Company / 2025-11-28 Semiconductors
[Disclosure] Hanwha Systems (272210) – Corrected Filing for Subsidiary HS USA Holdings Corp. Capital Increase (Payment Date Revised to Dec 22, 2025) Disclosures
[Disclosure] Hanwha Aerospace (012450) Amends Contract Completion Schedule for KF-X Engine Supply Due to Cost Settlement Process (Contract Value Unchanged at KRW 241B) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme